Halozyme Therapeutics Inc (HALO)

[Skeetz99]

Then its simple; Roche will need to lower its pricing to compete effectively. I am sure their are doctors who will maintain prescribing a branded product is better (for something very serious like Breast cancer). So I dont believe this will have a very dramatic affect ....but it will certainly lower the prospects of revenue expectations going forward.